NephroPOC - Risk assessment and prediction of acute kidney injury in emergency patients with suspected organ dysfunction: Secondary analysis from the prospective observational LifePOC study
Open Access
- 18 February 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0339763
Abstract
We aimed to assess markers and risk factors for imminent acute kidney injury (AKI) in emergency patients, as risk stratification in the emergency department is currently not widely used. Using data from a sub-cohort (440 patients) of the prospective multicentre LifePOC study (1434 patients), proenkephalin A 119−159 (penKid) was assessed for early identification of subclinical kidney damage compared to serum creatinine in emergency patients with a qSOFA score ≥1. Logistic regression was applied to assess the usefulness of penKid, four further biomarkers (midregional pro-adrenomedullin, bioactive adrenomedullin, dipeptidyl-peptidase-3, procalcitonin) and clinical risk factors to predict AKI within 24 h, 48 h and 72 h after admission, need for organ support and 28-day mortality. PenKid and bio-adrenomedullin performed moderately to predict AKI within 48 h (AUC 0.645, 95% CI: 0.582–0.703 and AUC 0.647, 95% CI: 0.583–0.707, respectively). Pre-existing chronic kidney disease (OR 2.36, 95% CI: 1.06–5.27), confirmed sepsis (OR 2.41, 95% CI: 1.28–4.56), mechanical ventilation (OR 3.03, 95% CI: 1.48–6.19), and elevated levels of penKid (OR 2.21, 95% CI: 1.60–3.07) at admission were associated with an increased risk of AKI whereas a restrictive fluid management (OR 0.43, 95% CI: 0.26–0.71) was associated with a lower risk of AKI. Patients at high AKI risk may be identified based on specific risk factors, bio-ADM and penKid. The trial was registered in the German Registry for Clinical Trials (DRKS00011188) on 20 October 2016.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZZ0810B)
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZZ0810B)
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZZ0810B)
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZZ0810B)
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZZ0810B)
This publication has 44 references indexed in Scilit:
- Role of traditional and new biomarkers in the assessment of chronic kidney diseases: a comprehensive analysis of the biochemical, molecular and clinical dimensionsMolecular Biology Reports, 2025
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Medicine, 2021
- Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus ConferenceJAMA Network Open, 2020
- AKI: an increasingly recognized risk factor for CKD development and progressionJournal Of Nephrology, 2020
- Identification and validation of biomarkers of persistent acute kidney injury: the RUBY studyIntensive Care Medicine, 2020
- Ten shortcomings of the current definition of AKIIntensive Care Medicine, 2017
- Update on Biomarkers of Acute Kidney InjuryMolecular Diagnosis & Therapy, 2012
- Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patientsIntensive Care Medicine, 2009
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Acute Renal Failure in Critically Ill PatientsA Multinational, Multicenter StudyJAMA, 2005